Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Eosinophilic pustular folliculitis (EPF) is a skin disorder characterized by recurring itchy, red or skin-colored bumps and pustules (bumps containing pus). The condition is named after the fact that skin biopsies of this disorder find eosinophils (a type of immune cell) around hair follicles. The papules mostly appear on the face, scalp, neck and trunk and may persist for weeks or months. EPF affects males more than females.There are several variants of EPF includingclassic eosinophilic pustular folliculitis (mainly occurring in adults in Japan); HIV-associated EPF, also referred to as immunosuppression-associated EPF; and infantile EPF (with onset from birth or within the first year of life). Whether these are distinct disorders rather than variants of one disorder is controversial, partly because the underlying cause of EFP is not known.Several treatments have been described with variable results, including various oral or topical medications and phototherapy. In patients with HIV-associated disease, antiretroviral therapy tends to greatly diminish symptoms or even eliminate the condition.
No clinical trials have been registered for eosinophilic pustular folliculitis.
30 publications have been identified in PubMed for eosinophilic pustular folliculitis. Research spans Case Report / Case Series (66%), Review / Meta-Analysis (21%), and Other (14%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 19 | 66% |
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 5:25 PM UTC
Genetic and Rare Diseases Info Center
6 |
21% |
Other research | 4 | 14% |
Mendes BX (2026). [PMID: 41321086](https://pubmed.ncbi.nlm.nih.gov/41321086/). *Pediatr Dermatol*. [Review / Meta-Analysis]
Tsuritani M (2026). [PMID: 41858250](https://pubmed.ncbi.nlm.nih.gov/41858250/). *J Dermatol*. [Other]
Zhu D (2026). [PMID: 41847261](https://pubmed.ncbi.nlm.nih.gov/41847261/). *Clin Cosmet Investig Dermatol*. [Case Report / Case Series]
Mansaray L (2026). [PMID: 41442872](https://pubmed.ncbi.nlm.nih.gov/41442872/). *Ann Dermatol Venereol*. [Other]
Bai JQA (2026). [PMID: 42109950](https://pubmed.ncbi.nlm.nih.gov/42109950/). *Cureus*. [Case Report / Case Series]
Muslu Camcıoğlu İ (2026). [PMID: 41878705](https://pubmed.ncbi.nlm.nih.gov/41878705/). *Skin Appendage Disord*. [Case Report / Case Series]
Mendoza V (2026). [PMID: 41880155](https://pubmed.ncbi.nlm.nih.gov/41880155/). *J Investig Allergol Clin Immunol*. [Case Report / Case Series]
Hong S (2026). [PMID: 42176709](https://pubmed.ncbi.nlm.nih.gov/42176709/). *J Am Acad Dermatol*. [Review / Meta-Analysis]
Wang QX (2025). [PMID: 39891551](https://pubmed.ncbi.nlm.nih.gov/39891551/). *Clin Exp Dermatol*. [Review / Meta-Analysis]
Mansilla-Polo M (2025). [PMID: 40717929](https://pubmed.ncbi.nlm.nih.gov/40717929/). *Sultan Qaboos Univ Med J*. [Case Report / Case Series]
AI-curated news mentioning eosinophilic pustular folliculitis
Updated Sep 2, 2026
A case report highlights the rapid remission of refractory eosinophilic pustular folliculitis with facial involvement following treatment with upadacitinib. This finding may inform future therapeutic strategies for this rare skin condition.